Concepedia

ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells

Katarina Le Blanc, Francesco Dazzi, Karen English, Dominique Farge, Jacques Galipeau, Edwin M. Horwitz, Nadir Kadri, Mauro Krampera, Manoj M. Lalu, Jan A. Nolta,

Cytotherapy · 2025 · 40 citations · 18 references

DOIFull text

Open access

Concepts

References

18

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Katarina Le Blanc, Ida Rasmusson, Berit Sundberg et al. · The Lancet · 2004 · 2.7K citations

, , +12

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Katarina Le Blanc, Francesco Frassoni, Lynne M. Ball et al. · The Lancet · 2008 · 2.7K citations

, , +11

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

Olle Ringdén, Mehmet Uzunel, Ida Rasmusson et al. · Transplantation · 2006 · 1.1K citations

, , +15

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

Julián Panés, Damián García‐Olmo, Gert Van Assche et al. · The Lancet · 2016 · 1.1K citations

, , +15

Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint

Pawan Kumar Gupta, Anoop Chullikana, Mathiyazhagan Rengasamy et al. · Arthritis Research & Therapy · 2016 · 322 citations · Full text

, , +17